Category: St. Jude Medical
Kimberly-Clark subsidiary I-Flow sues a Kentucky doctor for off-label use of a pain pump that that allegedly injured a patient.
MASSDEVICE ON CALL — Kimberly-Clark subsidiary I-Flow filed a lawsuit against Kentucky surgeon Dr. Bruce Holladay for off-label use of a pain pump that allegedly resulted in injury to a patient, raising the spectre of a slippery slope of physicians held liable in patient injury lawsuits.
Holladay performed reconstructive surgery on a patient in 2007, implanting a pain pump in the patient's shoulder. When the patient later complained of shoulder pain, he was diagnosed with chondrolysis, a condition in which continuous administration of certain anesthetics can result in the destruction of cartilage.
Physicians from the Minneapolis Heart Institute Foundation and Mayo Clinic organize a one-day summit in the Twin Cities to focus on the recall of St. Jude Medical's Riata leads.
Physicians from the Minneapolis Heart Institute Foundation and the Mayo Clinic will huddle with electro-physiologists in the Twin Cities Jan. 20 to discuss strategies for dealing with the recall of the Riata defibrillator leads made by St. Jude Medical Inc. (NYSE:STJ).
The FDA slapped the St. Paul, Minn.-based cardiology device maker with a Class 1 recall for the Riata leads in December, after the company said they failed more frequently than previously reported.
The top three medical device stories for January 11, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com's coverage highlights our three biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Deep brain stimulation systems from St. Jude Medical helps manage symptoms of Parkinson's disease, study says.
A deep brain stimulation implant made by St. Jude Medical's (NYSE:STJ) proved effective in the treatment of patients Parkinson's disease, according to results published in The Lancet.
The 136-patient study compared patients suffering from Parkinson's who were implanted with St. Jude's Libra and LibraXP DBS systems with and without stimulation. The study enrolled patients who had suffered from Parkinson's for at least 5 years, or who had 6 hours a day with diminished motor symptom control and muscle ticks.
Volcano, CareFusion, St. Jude Medical and a clutch of other medical device firms tip their cap on the upcoming earnings season at the JP Morgan Conference.
A slew of medical device companies are providing a sneak preview of the upcoming earnings season at the JP Morgan Conference in San Francisco this week.
MassDevice is on site at the conference and will have updates coming throughout the week on one of the largest meetings of the medical technology investment community.
St. Jude Medical officials say the company likely to meet its guidance for fourth quarter in preliminary earnings announcement: CRM business drops 4 percent
Shares of St. Jude Medical (NYSE:STJ) jumped nearly 5% in early trading on Wall Street as the St. Paul, Minn.-based cardiac device maker said it was likely to meet its previously stated earnings guidance for the fourth quarter of 2011.
The top seven medical device stories for the week of January 2, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.